31.01.2012 - 01.02.2012

Pharma & Biotech Patent Litigation in Amsterdam

Pharma and Biotech patent law continues to evolve rapidly, perhaps faster than patent law in any other field, with numerous significant case law developments arising from new tactics being employed by generics in recent times.

Weiterlesen …

02.02.2012 - 03.02.2012

2nd Annual EUCRAF Workshop in Freiburg, Germany

Following the particularly well received first workshop in 2011 on monoclonal antibodies the 2012 two-days’ networking event presents a unique speakers’ panel from various Agencies from Europe and Japan and from pharma companies. The mixture of currently hot regulatory and scientific themes is not only of interest for specialists from agencies and industry involved in the approval of new biopharmaceuticals but also for those who define the relevant strategy and development programmes.

Weiterlesen …

07.02.2012

Biotech Meets Public: „Die Zusammenarbeit zwischen großen und kleinen Unternehmen im Innovationsprozess der Biotechnologie – eine Erfolgsstory?“

Weiterlesen …

17.02.2012

5th Berlin Conference on IP in Life Sciences

Monoclonal antibodies are the fastest growing segment within the biotech and pharmaceutical industry. Today, four of the top ten selling blockbusters are antibodies. Industry forecasts see global antibody sales rising to $58bn in 2014.

Weiterlesen …

23.02.2012 - 24.02.2012

Workshop und Kooperationsbörse „Biointerfaces 2012“ in Erfurt

Der Thüringer Wachstumskern BASIS steht mit seinen 20 Projektpartnern aus Forschung und Industrie für „BioAnalytics and Surfaces for Integration in Systems“.

Weiterlesen …

23.02.2012

Health Care Market India, Frankfurt am Main

How to shape your market strategy?

Weiterlesen …